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Objective: To investigate which ultrasound ﬁndings or serum biomarkers, including insulin-like growth
factor 1 (IGF-1) and insulin-like growth factor binding protein 1 and 3 (IGFBP-1 and IGFBP-3, respec-
tively), in the ﬁrst and early second trimesters are the best predictors for preterm delivery.
Materials and Methods: This was a caseecontrol study conducted between March 2011 and March 2013
with women presenting for routine antenatal care at 11e18 weeks. We collected serum samples from
pregnant women and stored them at 80C. All patients underwent cervical length (CL) measurement at
18e21 weeks. We retrieved frozen samples for analysis from women with subsequent preterm and term
delivery. Prediction models were developed using multivariate stepwise logistic regression. Receiver-
operating characteristics curves were used to determine the most useful cutoff point.
Results: Of the 72 women recruited, 24 women underwent spontaneous preterm delivery, and 48
women with term delivery were randomly selected as the control group, in a 1:2 ratio. The maternal
serum concentration of IGFBP-3 and CL were signiﬁcantly associated with preterm birth.
Conclusion: Among the various known ultrasound ﬁndings and serum biomarkers in the early mid-
trimester, only CL and IGFBP-3 are independent predictors for preterm delivery in asymptomatic women.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Preterm delivery (birth before 37 weeks of gestation) causes
substantial perinatal mortality and long-term morbidity in neo-
nates [1]. Because the rate of preterm delivery continues to rise [1],
the early detection of preterm delivery remains one of the major
focuses of antenatal care even in developed countries. In addition,
prenatal identiﬁcation of pregnancies at increased risk of preterm
birth is beneﬁcial in that it provides an opportunity for increased
prenatal monitoring [2] and preventive treatments such as pro-
gesterone [3e5] and cervical cerclage [6,7].
Sonographic cervical length (CL) measurement is known to be
the most useful tool available to assess the risk of spontaneous
pretermbirth in asymptomaticwomen inmidpregnancy [8]. Severaland Gynecology, College of
versity of Korea, 222 Banpo-
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bstetrics & Gynecology. Published bother screening measures and biomarkers have been proposed.
Serumaneuploidymarkers, especially alpha-fetoprotein (AFP), have
beenproposed as predictors for preterm delivery [9e12];moreover,
cholesterol levels are known to be associated with preterm delivery
[9]. Several biomarkers including interleukin-6 (IL-6) and tumor
necrosis factor-a (TNF-a)dthat have been previously measured in
the serum, amniotic ﬂuid, and vaginal ﬂuiddare known to be
associated with preterm birth in symptomatic women [13e15].
Most of the biomarkers are inﬂammatory markers, which are
extracted from the amniotic ﬂuid or vaginal discharge of symp-
tomatic pregnant women. Few studies have measured serum
biomarker levels in asymptomaticwomen in the earlymidtrimester.
Insulin-like growth factors (IGFs) play a role in the control of
fetal and placental growth [16]. In the circulation, IGFs are bound to
insulin-like growth factor binding protein-3 (IGFBP-3), which
prolongs the IGF half-life and delays its clearance [17]. Previous
studies have noted that phosphorylated IGFBP-1 in vaginal
discharge was associated with preterm birth [18]. However, limited
data are available on the relationship between IGFs and IGFBPs
during the early midtrimester and preterm delivery.
The aim of this study was to investigate which ultrasound
ﬁndings or serum biomarkers, including IGF-1, IGFBP-1, andy Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Clinical characteristics of patients enrolled in the study.
Cases (n ¼ 24) Controls (n ¼ 48) p
Age (y) 32 (29e34) 33 (31e36) 0.245
Height (cm) 160 (157e166) 162 (157e165) 0.650
Weight (kg) 54 (50e58) 56 (50e66) 0.099
Body mass index
(kg/m2)
21 (20e22) 22 (19e25) 0.062
Gestational age at
delivery (wk)
35 (34e36) 39 (38e40) <0.001
Birth weight (kg) 2.43 (2.24e2.78) 3.19 (3.03e3.40) <0.001
Nulliparity 14 (58.3) 23 (47.9) 0.460
Prior spontaneous
preterm birth
3 (12.5) 3 (6.3) 0.393
Values are expressed as numbers (%) and median (interquartile rage).
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dictors for preterm delivery.
Methods
This was a caseecontrol study conducted between March 2011
and March 2013 with women presenting for routine antenatal care
at 11e18 weeks, who consented to serum sampling for study pur-
poses at the Seoul St. Mary Hospital in Seoul, Korea. All patients
signed an informed consent form approved by the Ethics Com-
mittee at the Clinical Research Coordinating Center, Catholic
Medical Center. The study participants were only women with
singleton pregnancies. Women with the following characteristics
were excluded from this study: maternal diabetes, preeclampsia,
preterm delivery without spontaneous labor, macrosomia and fetal
growth restriction, known aneuploidy, major congenital malfor-
mation, and pregnancies lost to follow-up. Of the study partici-
pants, women with spontaneous preterm delivery from 24þ0 to
36þ6 weeks were classiﬁed as the case group. The control group
comprised women randomly selected from among the study par-
ticipants, matched according to maternal age and gestational age at
serum extraction, in a 1:2 ratio.
Obstetric history data were retrieved from electronic medical
records. Clinical and ultrasound variables included age, weight,
height, parity, a history of previous preterm delivery, body mass
index (BMI), neonatal birth weight, and CL measured at 18e21
gestational weeks. CL measurement was performed according to
the protocol established by Iams et al [19] and the shortest mea-
surement was used for each patient. A lipid panel, including total
cholesterol and high-density lipoprotein cholesterol, was obtained
at the ﬁrst visit. Serum measurements measured as part of routine
screening for aneuploidy included estriol, AFP, inhibin A, and hu-
man chorionic gonadotropin in the second trimester. These analy-
tes were expressed as adjusted multiple of medians (MoMs).
Biomarker measurements
At enrollment, serum samples were obtained from all partici-
pants at 11 and 18 weeks of gestation. Blood specimen collection
and preparation of EDTA plasma were performed using standard
operative procedures, with samples centrifuged and stored
at 80C until analysis. Laboratory personnel were blinded to the
pregnancy outcome status. Prior to biomarker analysis, the sample
was thawed and centrifuged. The resultant supernatant was
collected and analyzed. Concentrations of the following markers
were measured: IGF-1, IGFBP-1, IGFBP-3, C-reactive protein (CRP),
procalcitonin, neutrophil gelatinase-associated lipocalin (NGAL),
placental growth factor (PLGF), IL-2, IL-6, IL-10, IL-12, IL-17, inter-
feron gamma-g (IFN-g), and TNF-a. An enzyme-linked immuno-
sorbent assay (Abcam, Cambridge, UK) was used for IGF-1, IGFBP-3,
IGFBP-1, procalcitonin, NGAL, and PLGF analysis. An immuno-
turbidimetric assay (Beckman Coulter, Inc, Brea, CA, USA) was used
for CRP analysis. A multiplex bead-based immunoassay (MILLIPLEX
Map Human Cytokine/Chemokine Magnetic Bead Panel; Millipore
Corp., Billerica, MA, USA) run on a Luminex 200 instrument
(Luminex Corp, TX, USA) was used to quantify IL-2, IL-6, IL-10, IL-12,
IL-17, IFN-g, and TNF-a.
Statistical analysis
All statistical analyses were performed using SPSS software
(version 16.0; SPSS Inc., Chicago, IL, USA). The clinical characteris-
tics of the patients in the case and control groups were compared
using either the Chi-square or Fisher exact test for categoricalvariables, and the ManneWhitney U test for continuous variables.
The signiﬁcance level was limited to p values of less than 0.05.
Multivariate logistic regression with backward elimination was
performed to compute odds ratios (ORs) as well as 95% conﬁdence
intervals (CIs) to estimate the association between preterm birth
and each biomarker. Areas under the receiver-operating charac-
teristic (ROC) curve (AUCs) were calculated and compared.Results
During the study period, 463 women agreed to participate. A
total of 134 women were excluded due to maternal diabetes
(n ¼ 10), preeclampsia (n ¼ 12), multiple gestation (n ¼ 23), pre-
term delivery without spontaneous labor (n ¼ 31), macrosomia
(n¼ 2), fetal growth restriction (n¼ 25), known aneuploidy (n¼ 3),
major congenital malformation (n ¼ 5), and loss of follow-up
(n ¼ 23), which left 329 women for analysis. Among these, 24
women who underwent spontaneous preterm delivery were clas-
siﬁed as the case group. The control group (n ¼ 48) comprised
women with term delivery who were randomly selected from
among the study participants, matched according to maternal age
and gestational age at serum extraction, in a 1:2 ratio. The gesta-
tional age (median) at sampling and delivery were 12þ4 (range
10þ4e18þ1) and 38þ4 (range 25þ2e41þ2) weeks. The maternal
characteristics at recruitment and the pregnancy outcomes are
summarized in Table 1. The median gestational age at delivery in
the preterm group was 35 weeks. Women in the control group did
not differ from those in the preterm group with regard to maternal
age, height, weight, BMI, nulliparity, and prior spontaneous pre-
term birth.
The median concentrations of all biomarkers in the maternal
serum, and the CL in the two groups are shown in Table 2. Women
in the preterm group had signiﬁcantly higher levels of IGF-1
(0.3 ng/mL vs. 0 ng/mL; p ¼ 0.043), IGFBP-3 (226 ng/mL vs.
177 ng/mL; p < 0.001), AFP (1.217 MoM vs. 0.875 MoM; p ¼ 0.009),
and CL (3.22 cm vs. 3.9 cm; p ¼ 0.001). In the preterm group, there
was no signiﬁcant difference in the concentrations of other
biomarkers.
The multivariate analysis of the biomarker data is shown in
Table 3. Multivariate logistic regression with backward elimination
conﬁrmed that, evenwhen other risk factors were accounted for, an
elevated serum IGFBP-3 level (OR 1.010; 95% CI 1.001e1.019) and CL
(OR 0.296; 95% CI 0.115e0.765) were independent predictors of
spontaneous preterm delivery.
The ROC curves illustrating the predictive accuracy of serum
IGFBP-3 are shown in Figure 1A. The AUCwith 95% CIs in predicting
spontaneous preterm delivery was 0.790 (95% CI 0.663e0.886;
p < 0.001). The cutoff value of 194.9 predicted preterm delivery
Table 2
Comparison of biomarkers and cervical length in the preterm and full-term birth
groups.
Preterm birth
(n ¼ 24)
Full-term birth
(n ¼ 48)
p
Insulin-like growth factor-1
(ng/mL)
0.3 (0e8.83) 0 (0e0.53) 0.043
IGFBP-3 (ng/mL) 226 (213e261) 177 (124e239) <0.001
IGFBP-1 (ng/mL) 27 (22.2e40.7) 25.5 (16.5e40.4) 0.809
C-reactive protein (mg/L) 1.13 (0.24e2.73) 1.21 (0.5e2.44) 0.692
Procalcitonin (pg/mL) 51.6 (10.7e214) 32.1 (4.30e143) 0.379
Neutrophil gelatinase-
associated lipocalin
(ng/mL)
16.5 (14.9e19.2) 19.2 (16.3e34) 0.067
Placental growth factor
(pg/mL)
334 (213e486) 364 (264e474) 0.344
IL-10 (pg/mL) 0.1 (0.1e0.1) 0.1 (0.1e0.1) 0.255
IL-12 (pg/mL) 0.1 (0.1e0.1) 0.1 (0.1e0.1) 1.00
IL-17 (pg/mL) 0.1 (0.1e0.1) 0.1 (0.1e0.1) 0.364
IL-2 (pg/mL) 0.1 (0.1e0.1) 0.1 (0.1e0.1) 0.356
IL-6 (pg/mL) 0.1 (0.1e0.1) 0.1 (0.1e0.1) 0.520
Interferon-g (pg/mL) 0.1 (0.1e0.875) 0.1 (0.1e0.8) 0.970
Tumor necrosis factor-a
(pg/mL)
6.45 (5.58e8.50) 6.70 (4.90e8.80) 0.548
Total cholesterol (mg/dL) 191.5 (172.8e225.5) 188 (170e213) 0.562
High-density lipoprotein
cholesterol (mg/dL)
64.5 (51e73.5) 57 (53e63) 0.131
Alpha-fetoprotein (MoM) 1.217 (0.887e1.423) 0.875 (0.760e1.07) 0.009
Estriol (MoM) 0.925 (0.718e1.09) 0.948 (0.776e1.27) 0.481
Inhibin (MoM) 1.035 (0.789e1.26) 1.03 (0.763e1.37) 0.957
Human chorionic
gonadotropin (MoM)
1.02 (0.856e1.38) 0.854 (0.685e1.48) 0.550
Cervical length (cm) 3.22 (2.40e3.89) 3.9 (3.4e4.65) 0.001
Values are expressed as median (interquartile rage).
IGFBP-3 ¼ insulin-like growth factor binding protein 3; IL ¼ interleukin;
MoM ¼ multiple of the medians.
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with 95% CIs in predicting spontaneous preterm delivery was 0.745
(95% CI 0.628e0.840; p < 0.001; Figure 1B). The cutoff value of 3
predicted preterm delivery with sensitivity of 50% and speciﬁcity of
89.58%.Discussion
In this study, only CL and IGFBP-3 in the earlymidtrimester were
independent predictors for preterm delivery in asymptomatic
women. Other inﬂammatory markers, serum aneuploidy markers,
and lipid proﬁle were not predictive of preterm delivery.
Few studies investigated the association of preterm birth and
IGF family.Wang et al [20] suggested that neither IGF-1 nor IGFBP-1
appears to play a signiﬁcant role in preterm delivery, as maternal
serum IGF-1 and IGFBP-1 levels are similar in preterm and term
deliveries. Another study showed that maternal serum IGFBP-3
levels are signiﬁcantly reduced in cases complicated by delivery
at less than 32 weeks of gestation [21]. Similar to our ﬁndings,
previous studies have shown that IGF-1 and IGFBP-1 are notTable 3
Univariate and multivariate logistic regression for the prediction of spontaneous preterm
Univariate ana
OR 95% CI
Insulin-like growth factor-1 1.152 0.938e1.414
Insulin-like growth factor binding protein-3 1.011 1.002e1.020
Alpha-fetoprotein 7.505 1.521e37.01
Cervical length 0.322 0.160e0.646
CI ¼ conﬁdence interval; OR ¼ odds ratio.associated with preterm delivery; however, we also found that
higher concentrations of IGFBP-3 are associated with preterm de-
livery. The difference between our results and those from the
previous study could have resulted from including only singleton
spontaneous preterm deliveries, with controls matched for gesta-
tional age at serum extraction, to account for differences in con-
centration according to the gestational age. Serum IGF-1 levels
increased progressively according to the gestational age [20], and
thematernal circulating IGFBP-1 concentration increased rapidly in
the ﬁrst trimester and reached a plateau at term [21]. Moreover, the
difference may be attributed to racial differences. Menon [22] re-
ported racial differences in cytokine levels.
In addition, our study has evaluated serum inﬂammatory
markers in the early midtrimester in asymptomatic pregnant
women. Few studies have investigated the relationship between
serum inﬂammatory cytokines in early gestation and spontaneous
preterm delivery, with matching for gestational age. We have
showed that inﬂammatory markers were not associated with pre-
term birth. These ﬁndings are compatible with the results of a
previous study, which showed that there was no difference in the
serum inﬂammatory cytokine levels of the preterm and term
groups at 15 and 18 weeks' gestation [23].
A possible explanation for this result may be that inﬂammatory
changes in maternal serum occur at a later stage, after the local
inﬂammation. Yang et al [23] suggested that 15e18 weeks may be
too early for changes to appear in the maternal serum cytokine
levels. The amniotic ﬂuid, which largely consists of fetal urine, was
more indicative of the fetal immune proﬁle than the placenta or
maternal blood in early midtrimester women without evidence of
infection [24]. Another study showed that an inﬂammatory
response mediated by CRP in women with preterm prelabor
rupture of membranes with microbial invasion of the amniotic
cavity was observed in the cervical compartment, but not in the
serum [25]. Therefore, earlier inﬂammatory change may be
observed in the amniotic ﬂuid or cervical discharge, not in the
maternal serum.
The IGF family is known to display pleiotropic properties,
including the ability to promote cellular proliferation, differentia-
tion, and metabolism/hypertrophy [26]. Impairment of placenta-
tion, placental ischemia, and fetal growth in earlier gestation
induced by the IGF family might inﬂuence the occurrence of
spontaneous preterm delivery. Similarly, Goetzinger et al [27]
argued that impaired placentation may contribute to preterm la-
bor by biomarker and Doppler examination during the ﬁrst
trimester [27].
There are some limitations to our study. First, the small sample
size may have led to results with wide CIs. Second, our case group
consisted mostly of late preterm deliveries, with a limited number
of early preterm deliveries less than 28 gestational weeks.
One of the strengths of the study was that we compared several
biomarkers concurrently, including inﬂammatory markers, IGF
family, serum aneuploidy markers, and lipid panel, to determine
the best biomarkers, and ultimately improve the knowledge of the
pathophysiology of spontaneous preterm deliveries. In addition,delivery.
lysis Multivariate analysis
p OR 95% CI p
0.177 1.108 0.906e1.356 0.318
0.012 1.010 1.001e1.019 0.026
9 0.013 7.849 0.736e83.678 0.088
0.001 0.296 0.115e0.765 0.012
Figure 1. Receiver operating curve for prediction of preterm delivery. (A) Insulin-like
growth factor binding protein 3. (B) Cervical length.
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preterm birth during the ﬁrst and early second trimesters and by
using maternal serum. Finally, we accounted for the differences
associated with the gestational age at serum extraction by match-
ing the sampling gestational age.
In conclusion, our ﬁndings suggest that only CL and IGFBP-3 in
early midtrimester are independent predictors for preterm delivery
in asymptomatic pregnant women, and other inﬂammatory
markers in earlier gestation were not associated with preterm de-
livery. A larger, prospective study with plasma and cervical or
vaginal ﬂuid samples assayed at different time points in gestation
may provide more detailed information about the role of various
biomarkers in preterm labor.Conﬂicts of interest
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